Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Werewolf Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Werewolf Therapeutics

Werewolf Therapeutics

Public

Werewolf Therapeutics, an immuno-oncology firm, pioneers transformative cancer treatments.

HQ
Watertown, WI, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Werewolf Therapeutics is an immuno-oncology company dedicated to developing transformative cancer treatments. The company focuses on creating systemically delivered targeted therapies that address the limitations of current immunotherapy approaches. Their technology is designed to unleash proven proinflammatory mechanisms on tumors while minimizing unwanted side effects on non-target tissue.

The company's innovative approach aims to overcome the challenges of off-target effects in clinical settings, a common issue with existing immunotherapies. Werewolf Therapeutics is advancing a pipeline of next-generation cancer treatments, striving to make a significant impact in the field of oncology and improve outcomes for cancer patients.

Werewolf Therapeutics - Similar Companies

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Palm Therapeutics logo

Palm Therapeutics

Imvaq Therapeutics logo

Imvaq Therapeutics

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

Oncofactor logo

Oncofactor

oncofactor.com

CytomX Therapeutics logo

CytomX Therapeutics

cytomx.com

BioEclipse Therapeutics logo

BioEclipse Therapeutics

bioeclipse.com

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Tizona Therapeutics logo

Tizona Therapeutics

tizonatx.com

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

Seneca Therapeutics logo

Seneca Therapeutics

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

Treadwell Therapeutics logo

Treadwell Therapeutics

treadwelltx.com

Werewolf Therapeutics - Quick Facts

Who are Werewolf Therapeutics' competitors?

Companies similar to Werewolf Therapeutics include PanTher Therapeutics, Window Therapeutics, Immune-Onc Therapeutics and Palm Therapeutics.

When was Werewolf Therapeutics founded?

Werewolf Therapeutics was founded in 2017.

Where is Werewolf Therapeutics' headquarters located?

Werewolf Therapeutics' headquarters is located in Watertown, WI, US.

When was Werewolf Therapeutics' last funding round?

Werewolf Therapeutics' most recent funding round was for $72M (USD) in January 2021.

How much has Werewolf Therapeutics raised to-date?

As of Jan 7, 2021, Werewolf Therapeutics has raised a total of $128.2M (USD).

How many employees does Werewolf Therapeutics have?

Werewolf Therapeutics has 50 employees as of Feb 6, 2024.

Werewolf Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Healthtech
Unique IDs
  • ein: 823523180
  • secCik: 0001785530
  • ticker: HOWL
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research